T. Rowe Price Associates’s HashiCorp, Inc. Class A Common Stock HCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-119,491
Closed -$4.09M 3093
2024
Q4
$4.09M Sell
119,491
-44,621
-27% -$1.51M ﹤0.01% 1344
2024
Q3
$5.56M Sell
164,112
-32,335
-16% -$1.09M ﹤0.01% 1261
2024
Q2
$6.62M Sell
196,447
-123,232
-39% -$3.83M ﹤0.01% 1173
2024
Q1
$8.62M Sell
319,679
-542,551
-63% -$13.1M ﹤0.01% 1136
2023
Q4
$20.4M Buy
862,230
+392,494
+84% +$8.5M ﹤0.01% 951
2023
Q3
$10.7M Sell
469,736
-1,215,741
-72% -$33M ﹤0.01% 1065
2023
Q2
$44.1M Sell
1,685,477
-6,458,650
-79% -$189M 0.01% 739
2023
Q1
$239M Sell
8,144,127
-3,291,214
-29% -$98.3M 0.04% 349
2022
Q4
$313M Buy
11,435,341
+2,368,102
+26% +$67M 0.05% 302
2022
Q3
$292M Buy
9,067,239
+2,606,710
+40% +$90M 0.05% 304
2022
Q2
$190M Buy
6,460,529
+1,776,699
+38% +$71.7M 0.02% 493
2022
Q1
$253M Sell
4,683,830
-1,049,686
-18% -$61.1M 0.03% 468
2021
Q4
$516M Buy
+5,733,516
New +$499M 0.05% 347

Other funds holding HCP

T. Rowe Price Associates's HCP Position: Q1 2025 in Review

T. Rowe Price Associates sold out of HashiCorp, Inc. Class A Common Stock (HCP) in Q1 2025, closing a stake of 119,491 shares — an estimated $4.09M sold.

T. Rowe Price Associates first reported a position in HCP in Q4 2021 and held it in 13 quarters. The position peaked at $516M in Q4 2021. 4 funds tracked by Wall St. Rank hold HCP as of Q1 2025.

  • T. Rowe Price Associates reported no remaining HashiCorp, Inc. Class A Common Stock position as of Q1 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 119,491 HashiCorp, Inc. Class A Common Stock shares in Q1 2025, an estimated $4.09M.
  • T. Rowe Price Associates first reported a position in HashiCorp, Inc. Class A Common Stock in Q4 2021 and held it in 13 quarters.
  • T. Rowe Price Associates's HashiCorp, Inc. Class A Common Stock position peaked at $516M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held HashiCorp, Inc. Class A Common Stock as of Q1 2025.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.